250 related articles for article (PubMed ID: 19777788)
21. Expression and significance of mammalian target of rapamycin in cutaneous squamous cell carcinoma and precancerous lesions.
Xu G; Fang J; Xu J; Shen Z; Huang C; Jiang Y
Bioengineered; 2021 Dec; 12(2):9930-9938. PubMed ID: 34874800
[TBL] [Abstract][Full Text] [Related]
22. Stromal CD10 expression, as well as increased dermal macrophages and decreased Langerhans cells, are associated with malignant transformation of keratinocytes.
Takahara M; Chen S; Kido M; Takeuchi S; Uchi H; Tu Y; Moroi Y; Furue M
J Cutan Pathol; 2009 Jun; 36(6):668-74. PubMed ID: 19515046
[TBL] [Abstract][Full Text] [Related]
23. Expression of bcl-2, p53 and Ki-67 in arsenical skin cancers.
Chang CH; Tsai RK; Chen GS; Yu HS; Chai CY
J Cutan Pathol; 1998 Oct; 25(9):457-62. PubMed ID: 9821074
[TBL] [Abstract][Full Text] [Related]
24. Expression of p300 and p300/CBP associated factor (PCAF) in actinic keratosis and squamous cell carcinoma of the skin.
Bosic MM; Brasanac DC; Stojkovic-Filipovic JM; Zaletel IV; Gardner JM; Cirovic SL
Exp Mol Pathol; 2016 Jun; 100(3):378-85. PubMed ID: 27019369
[TBL] [Abstract][Full Text] [Related]
25. Significance of cyclooxygenase 2, EZH-2 polycomb group and p53 expression in actinic keratosis and squamous cell carcinomas of the skin.
Athanassiadou AM; Lazaris AC; Patsouris E; Tsipis A; Chelidonis G; Aroni K
Am J Dermatopathol; 2013 Jun; 35(4):425-31. PubMed ID: 23095338
[TBL] [Abstract][Full Text] [Related]
26. CCR10 and CCL27 are overexpressed in cutaneous squamous cell carcinoma.
Kai H; Kadono T; Kakinuma T; Tomita M; Ohmatsu H; Asano Y; Tada Y; Sugaya M; Sato S
Pathol Res Pract; 2011 Jan; 207(1):43-8. PubMed ID: 21144674
[TBL] [Abstract][Full Text] [Related]
27. Expression of granulocyte colony-stimulating factor and its receptor in epithelial skin tumors.
Hirai K; Kumakiri M; Fujieda S; Sunaga H; Lao LM; Imamura Y; Ueda K; Fukuda M
J Dermatol Sci; 2001 Apr; 25(3):179-88. PubMed ID: 11240265
[TBL] [Abstract][Full Text] [Related]
28. Expression of proliferating cell nuclear antigen (PCNA) and apoptosis related antigen (LeY) in epithelial skin tumors.
Tsuji T; Kitajima S; Koashi Y
Am J Dermatopathol; 1998 Apr; 20(2):164-9. PubMed ID: 9557786
[TBL] [Abstract][Full Text] [Related]
29. Perianal Bowen's disease: a clinicopathologic study of 47 patients.
Marchesa P; Fazio VW; Oliart S; Goldblum JR; Lavery IC
Dis Colon Rectum; 1997 Nov; 40(11):1286-93. PubMed ID: 9369101
[TBL] [Abstract][Full Text] [Related]
30. p53 expression and proliferative activity in Bowen's disease with or without chronic arsenic exposure.
Kuo TT; Hu S; Lo SK; Chan HL
Hum Pathol; 1997 Jul; 28(7):786-90. PubMed ID: 9224745
[TBL] [Abstract][Full Text] [Related]
31. In vivo microvascular imaging of cutaneous actinic keratosis, Bowen's disease and squamous cell carcinoma using dynamic optical coherence tomography.
Themstrup L; Pellacani G; Welzel J; Holmes J; Jemec GBE; Ulrich M
J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1655-1662. PubMed ID: 28502083
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of enhancer of Zeste Homolog 2 (EZH2) differentiates squamous cell carcinoma from normal skin and actinic keratosis.
Xie Q; Wang H; Heilman ER; Walsh MG; Haseeb MA; Gupta R
Eur J Dermatol; 2014; 24(1):41-5. PubMed ID: 24413452
[TBL] [Abstract][Full Text] [Related]
33. Epithelial-to-mesenchymal transition contributes to invasion in squamous cell carcinomas originated from actinic keratosis through the differentiated pathway, whereas proliferation plays a more significant role in the classical pathway.
Saenz-Sardà X; Carrato C; Pérez-Roca L; Puig L; Ferrándiz C; Ariza A; Fernández-Figueras MT
J Eur Acad Dermatol Venereol; 2018 Apr; 32(4):581-586. PubMed ID: 28796927
[TBL] [Abstract][Full Text] [Related]
34. [Expression of E-cadherin and beta-catenin in Bowen's disease and squamous cell carcinoma].
Li ZX; Peng ZH; Ji FP; Yuan JY; Pan M; Liu Y; Wang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1245-7. PubMed ID: 16939929
[TBL] [Abstract][Full Text] [Related]
35. Expression of metallothioneins in cutaneous squamous cell carcinoma and actinic keratosis.
Zamirska A; Matusiak Ł; Dziegiel P; Szybejko-Machaj G; Szepietowski JC
Pathol Oncol Res; 2012 Oct; 18(4):849-55. PubMed ID: 22407324
[TBL] [Abstract][Full Text] [Related]
36. Comparative histochemical study of Bowen's disease and actinic keratosis: preserved normal basal cells in Bowen's disease.
Ishida H; Kumakiri M; Ueda K; Lao LM; Yanagihara M; Asamoto K; Imamura Y; Noriki S; Fukuda M
Eur J Histochem; 2001; 45(2):177-90. PubMed ID: 11512639
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical study of cyclooxygenase-2 in skin tumors.
Amirnia M; Babaie-Ghazani A; Fakhrjou A; Khodaeiani E; Alikhah H; Naghavi-behzad M; Zarrintan A
J Dermatolog Treat; 2014 Oct; 25(5):380-7. PubMed ID: 22667343
[TBL] [Abstract][Full Text] [Related]
38. Reduced human mismatch repair protein expression in the development of precancerous skin lesions to squamous cell carcinoma.
Liang SB; Furihata M; Takeuchi T; Sonobe H; Ohtsuki Y
Virchows Arch; 2001 Nov; 439(5):622-7. PubMed ID: 11764381
[TBL] [Abstract][Full Text] [Related]
39. Cytokeratin 17 immunoexpression in actinic keratosis (bowenoid and nonbowenoid) and in Bowen disease.
Fernandez-Flores A
Ann Diagn Pathol; 2016 Feb; 20():1-6. PubMed ID: 26740287
[TBL] [Abstract][Full Text] [Related]
40. Assessment of cell proliferation in benign, premalignant and malignant skin lesions.
Bordbar A; Dias D; Cabral A; Beck S; Boon ME
Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):229-35. PubMed ID: 17525640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]